This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Luyken, J. Articles by Rothblum, L. I. Search for Related Content PubMed PubMed Citation Articles by Luyken, J. Articles by Rothblum, L. I. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB 12-O-TETRADECANOYLPHORBOL-13-ACETATE

(Circulation Research. 1996;78:354-361.)
© 1996 American Heart Association, Inc.

Articles

Regulation of rDNA Transcription During Endothelin-1Induced Hypertrophy of Neonatal Cardiomyocytes

Hyperphosphorylation of Upstream Binding Factor, an rDNA Transcription Factor

Joachim Luyken, Ross D. Hannan, Joseph Y. Cheung, Lawrence I. Rothblum

From the Sigfried and Janet Weis Center for Research, Geisinger Clinic, Danville, Pa.

Correspondence to Dr Lawrence I. Rothblum, Geisinger Clinic, Sigfried and Janet Weis Center for Research, Danville, PA 17882. E-mail lrothblum@geisinger.edu.

Abstract Treatment of cultured neonatal cardiomyocytes with endothelin-1 and phorbol 12-myristate 13-acetate (PMA) results in cardiomyocyte hypertrophy. However, the signal transduction pathways involved in this process are poorly understood. Because increased ribosome biogenesis is a requisite for hypertrophy, we sought to (1) confirm the hypothesis that these two hypertrophic agents did indeed induce rRNA synthesis and (2) examine the mechanism through which this induction was accomplished. In this study, hypertrophy of contraction-arrested neonatal cardiomyocytes induced by treatment with either endothelin-1 or PMA was associated with increased rDNA transcription. Western blots demonstrated that the enhanced rates of rDNA transcription were not mediated by increased amounts of either RNA polymerase I or upstream binding factor (UBF), an rDNA transcription factor. However, immunoprecipitation of [³²P]orthophosphate-labeled UBF from hypertrophying neonatal cardiomyocytes suggested that the increased rate of rDNA transcription may be due to the hyperphosphorylation of UBF, which would increase the activity of UBF. The increase in UBF phosphorylation occurred within 3 to 6 hours after exposure to either agent, was maximal at 12 hours, and was sustained for at least the first 24 hours of exposure. Phosphoamino acid analysis of UBF immunoprecipitated from control and treated cardiomyocytes demonstrated that UBF was phosphorylated exclusively on serine residues. Our previous studies have shown that the cellular UBF content increased in adrenergic- and contraction-induced models of cardiac hypertrophy. This study with endothelin-1 and PMA demonstrates that the modulation of UBF phosphorylation is an additional pathway by which ribosome biogenesis may be regulated in neonatal cardiomyocytes. These results support the hypothesis that UBF is an important regulatory factor during the initiation and maintenance of the accelerated rate of rDNA transcription observed during neonatal cardiomyocyte hypertrophy mediated by both phorbol esters and endothelin-1.

Key Words: cardiomyocyte hypertrophy • upstream binding factor • rDNA • endothelin-1 • phorbol 12-myristate 13-acetate

This article has been cited by other articles:

				K. Lister, D. J. Autelitano, A. Jenkins, R. D. Hannan, and K. E. Sheppard Cross talk between corticosteroids and alpha-adrenergic signalling augments cardiomyocyte hypertrophy: A possible role for SGK1 Cardiovasc Res, June 1, 2006; 70(3): 555 - 565. [Abstract] [Full Text] [PDF]

				M. J. James and J. C. B. M. Zomerdijk Phosphatidylinositol 3-Kinase and mTOR Signaling Pathways Regulate RNA Polymerase I Transcription in Response to IGF-1 and Nutrients J. Biol. Chem., March 5, 2004; 279(10): 8911 - 8918. [Abstract] [Full Text] [PDF]

				K. M. Hannan, Y. Brandenburger, A. Jenkins, K. Sharkey, A. Cavanaugh, L. Rothblum, T. Moss, G. Poortinga, G. A. McArthur, R. B. Pearson, et al. mTOR-Dependent Regulation of Ribosomal Gene Transcription Requires S6K1 and Is Mediated by Phosphorylation of the Carboxy-Terminal Activation Domain of the Nucleolar Transcription Factor UBF{dagger} Mol. Cell. Biol., December 1, 2003; 23(23): 8862 - 8877. [Abstract] [Full Text] [PDF]

				I. Hirschler-Laszkiewicz, A. Cavanaugh, Q. Hu, J. Catania, M. L. Avantaggiati, and L. I. Rothblum The role of acetylation in rDNA transcription Nucleic Acids Res., October 15, 2001; 29(20): 4114 - 4124. [Abstract] [Full Text] [PDF]

				H. Ehmke, J. Faulhaber, K. Munter, M. Kirchengast, and R. J. Wiesner Chronic ETA Receptor Blockade Attenuates Cardiac Hypertrophy Independently of Blood Pressure Effects in Renovascular Hypertensive Rats Hypertension, April 1, 1999; 33(4): 954 - 960. [Abstract] [Full Text] [PDF]

				A. J. Kihm, J. C. Hershey, T. A. J. Haystead, C. S. Madsen, and G. K. Owens Phosphorylation of the rRNA transcription factor upstream binding factor promotes its association with TATA binding protein PNAS, December 8, 1998; 95(25): 14816 - 14820. [Abstract] [Full Text] [PDF]

				T. H. Larsen and T. Sætersdal Translocation of 60S Ribosomal Subunit in Spreading Cardiac Myocytes J. Histochem. Cytochem., August 1, 1998; 46(8): 963 - 970. [Abstract] [Full Text]